Rockefeller Capital Management
CTSO icon

Rockefeller Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Rockefeller Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618 Sell
1,652
-209
-11% -$110 ﹤0.01% 4579
2026
Q1 		$1.05K Sell
1,861
-705
-27% -$481 ﹤0.01% 4482
2025
Q4 		$1.64K Buy
2,566
+1,566
+157% +$1.21K ﹤0.01% 4367
2025
Q3 		$934 Buy
+1,000
New +$985 ﹤0.01% 4195

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Rockefeller Capital Management's CTSO Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Cytosorbents Corp (CTSO) stake by 11% in Q2 2026, selling an estimated $110 and leaving 1,652 shares worth $618. The position accounts for ﹤0.01% of the portfolio, ranked #4579.

Rockefeller Capital Management first reported a position in CTSO in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.64K in Q4 2025. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Rockefeller Capital Management held 1,652 shares of Cytosorbents Corp worth $618 as of Q2 2026.
  • Rockefeller Capital Management sold 209 Cytosorbents Corp shares in Q2 2026, an estimated $110.
  • Cytosorbents Corp made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4579 holding.
  • Rockefeller Capital Management first reported a position in Cytosorbents Corp in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Cytosorbents Corp position peaked at $1.64K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.